Triamcinolone: new and old indications

Bibliography

• LUNG HEALTH STUDY RESEARCH GROUP: Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive pulmonary Disease. N Engl. J. Med. (2000) 343:1902–1909.
   PubMed Web of Science ®Google Scholar
• ••Major recent clinical trial of TAA inCOPD.
   Google Scholar
• BARNES PJ: Anti-inflammatory actions ofglucocorticoids: molecular mechanism. Sci. (Caleb) (1998) 94:557–572.
   Google Scholar
• •Recent review of the molecular mechanisms of glucocorticoids.
   Google Scholar
• ARGENTI D, SHAH B, HEALD D: A pharmacokinetic study to evaluate the absolute bioavailability of triamcinolone acetonide following inhalation administration. j Clio. Pharmacy]. (1999) 39:695–702.
   PubMed Web of Science ®Google Scholar
• WILSON AM, BREWSTER HJ, LIPS WORTH BJ: Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults. I Allergy Immunol. (1998) 102:751–756.
   PubMedGoogle Scholar
• WILSON AM, MCFARLANE LC, LIPWORTH BJ: Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. j Clin. Enclocnhyl. Metab. (1998) 83:922–925.
   PubMedGoogle Scholar
• BRUS R: Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults. Arch. Intern. Med. (1999) 159:1903–1908.
   PubMedGoogle Scholar
• NAYAK AS, ELLIS MH, GROSS GN etal.: The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis. Allergy Clio. brununyl. (1998) 101:157–162.
   Google Scholar
• WELCH MJ, BRONSKY E, FINDLAY D et al.: Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis. Clin. Ther. (1994) 16:253–262.
   PubMedGoogle Scholar
• SORKNESS CA, LAFORCE C, STORMS W etal.: Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. Gun. Ther. (1999) 21:353–367.
   Google Scholar
• FINDLAY S, HUBER F, GARCIA J, HUANG L: Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann. Allergy (1992) 68:228–232.
   PubMedGoogle Scholar
• •An early demonstration of the benefit of TAA in rhinitis.
   Google Scholar
• SPECTOR S, BRONSKY E, CHERVINSKY P etal.: Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann. Allergy (1990) 64:300–305.
   Google Scholar
• STORMS W, BRONSKY E, FINDLAY S et al.: Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann. Allergy (1991) 66:329–334.
   PubMedGoogle Scholar
• MUNK ZM, LAFORCE C, FURST JA, SIMPSON B, FEISS G, SMITH JA: Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann. Allerg. Asthma Immurrol (1996) 77:277–281.
   PubMedGoogle Scholar
• MUNK ZM, GROSS GN, HAMPEL FC, RATNER PH: Preseasonal, once daily triamcinolone acetonide nasal aerosol for seasonal allergic rhinitis. Ann. Allergy Asthma Immurrol (1997) 78:325–331.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL R, BERGER W, BRONSKY E et al.: Tr-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass season. Am. j Rhino]. (1998) 12:427–433.
   PubMedGoogle Scholar
• KOBAYASHI RH, BEAUCHER WN, KOEPKE JW et al: Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study. OM. Ther. (1995) 17:503–513.
   Google Scholar
• KOEPKE JW, BEAUCHER WN, KOBAYASHI RH etal.: Long-term safety and efficacy of triamcinolone acetonide aqueous nasal spray for the treatment of perennial allergic rhinitis. Allergy Asthma Proc. (1997) 18:33–37.
   Google Scholar
• BANOV CH, SILVERS WS, GREEN AW et al.: Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. Clmn. Ther. (1996) 18:265–272.
   PubMedGoogle Scholar
• DAY JH, BUCKERIDGE DL, CLARK RH, BRISCOE MP, PHILLIPS R: A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone nasal spray in subjects with ragweed-induced allergic rhinitis. j Allergy Immurrol. (1996) 97:1050–1057.
   PubMedGoogle Scholar
• HOWLAND WC, DOCKHORN R, GILLMAN S et al: A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisolone, and placebo on adrenocortical function in male patients with allergic rhinitis. j Allergy Clin. Immurrol (1996) 98:32–38.
   PubMedGoogle Scholar
• LALIBERTE 1 LALIBERTE MF, LECART S et al: Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study Group. Allergy (2000) 55:718–722.
   Google Scholar
• BERNSTEIN DI, CRETICOS PS, BUSSE WW et al.: Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. I Allergy Clin. Immurrol. (1996) 97:749–755.
   PubMed Web of Science ®Google Scholar
• GAWCHIK SM, LIM J: Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis. Am. Management Care (1997) 3:1052–1058.
   PubMed Web of Science ®Google Scholar
• CONDEMI J, SCHULZ R, LIM J: Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann. Allergy Asthma Immurrol (2000) 84:533–538.
   PubMed Web of Science ®Google Scholar
• SMALL P, HOULE PA, DAY JH et al: Acomparison of triamcinolone acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the treatment of spring allergic rhinitis. Allergy Clin. Immurrol. (1997) 100:592–595.
   PubMedGoogle Scholar
• WELCH MJ, LEVY S, SMITH JA, FEISS G, FARRAR JR: Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma. Chest (1997) 112:597–606.
   PubMed Web of Science ®Google Scholar
• ••Trial demonstrating effectiveness inbronchial asthma.
   Google Scholar
• BERNSTEIN DI, COHEN R, GINCHANSKY E et al.: A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild- to-moderate asthma. j Allergy Clin. Immurrol (1998) 101:433–438.
   PubMed Web of Science ®Google Scholar
• RAMSDELL JW, FISH L, GRAFT D et al: A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma. Am. Allergy Asthma Immurrol. (1998) 80:385–390.
   PubMedGoogle Scholar
• JACOBSEN K, CHERVINSKY P, NOONAN M et al.: Placebo-controlled, comparative study of the efficacy and safety of trimcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group. Ann. Allergy Asthma Immurrol (1999) 83:327–333.
   PubMedGoogle Scholar
• WELCH M, BERNSTEIN D, GROSS G, KANE RE, BANERJI D: A controlled trial of chlorofluorocarbon-free triamcinolone acetonide in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group. Chest (1999) 116:1304–1312.
   Google Scholar
• NELSON HS, KANE RE, PETILLO J, BANERJI D: Long-term safety of a non-chlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma. Azmacort HFA Study Group.j Asthma (2000) 37:145–152.
   PubMed Web of Science ®Google Scholar
• CONDEMI JJ, CHERVINSKY P, GOLDSTEIN MF et al: Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. Allergy OM. Immurrol (1997) 100:467–474.
   PubMedGoogle Scholar
• BARANIUK J, MURRAY JJ, NATHANRA et al.: Fluticasone alone or in combination with salmeterol vs. triamcinolone in asthma. Chest (1999) 116:625–632.
   PubMedGoogle Scholar
• BRONSKY E, KORENBLAT P, HARRIS AG, CHEN R: Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma. Ann. Allergy Asthma Immurrol. (1998) 80:295–302.
   PubMedGoogle Scholar
• BERKOWITZ R, RACHELEFSKY G, HARRIS AG, CHEN R: A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics. Chest (1998) 114:757–765.
   PubMed Web of Science ®Google Scholar
• SCHUCKMAN H, DEJULIUS DP, BLANDA M, GERSON LW DEJULIUS AJ, RAJARATNAM M: Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial. Ann. Emerg. Med. (1998) 31:333–338.
   PubMedGoogle Scholar
• MANCINELLI L, NAVARRO L, SHARMA OP: Intramuscular high-dose triamcinolone acetonide in the treatment of severe chronic asthma. West j Med. (1997) 167:322–329.
   PubMedGoogle Scholar
• VESTBO J, SORENSEN T, LANGE P et al.: Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (1999) 353:1819–1823.
   PubMed Web of Science ®Google Scholar
• PAUWELS RA, LOFDAHL CG, LAITINEN LA et al.: Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl. Med. (1999) 340:1948–1953.
   Google Scholar
• BURGE PS, CALVERLEY PM, JONES PW etal.: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Br. Med. (2000) 320:1297–1303.
   Google Scholar
• MCCARTY DJ, HARMAN JG, GRASSANOVICH JL, QIAN C: Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide. j Rheumatol (1995) 22:1631–1535.
   PubMed Web of Science ®Google Scholar
• ••Review of benefit of triamcinolonehexacetonide in RA.
   Google Scholar
• BREIT W, FROSCH M, MEYER U, HEINECKE A, GANSER G: A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. j Rheumatol (2000) 27:2696–2702.
   PubMedGoogle Scholar
• SAINT JS, GUPTA A, PANDEY SK, GUPTA V, GUPTA P: Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis. Acta. Ophthalamol Scam/. (1999) 77:515–518.
   PubMedGoogle Scholar
• DANIS RP CIULLA TA, PRATT LM, ANLIKER W: Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina (2000) 20:244–250.
   PubMedGoogle Scholar
• DE JONG BA, DAHMEN R, HOGEWEG JA, MARTI RK: Intra-articular triamcinolone acetonide injection in patients with capsulitis of the shoulder: a comparative study of two dose regimens. Rehabil (1998) 12:211–215.
   Google Scholar
• SNELS IA, BECKERMAN H, TWISK JW: Effect of triamcinolone acetonide injections on hemiplegic shoulder pain: A randomized clinical trial. Stroke (2000) 31:2396–2401.
   PubMed Web of Science ®Google Scholar
• RITOTA PC, LO AK: Cushing's syndromein postburn children following intralesional triamcinolone injection. Ann. Plast. Surg. (1996) 36:508–511.
   PubMed Web of Science ®Google Scholar
• KETCHUM LD, DONAHUE TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. j Hand Surg. [And (2000) 25:1157–1162.
   PubMedGoogle Scholar
• ROANE DW, HARRIS MD, CARPENTER MT et al: Prospective use of intramuscular triamcinolone acetonide in pseudogout. j Rheumatol (1997) 24:1168–1170.
   PubMedGoogle Scholar
• WANG JJ, HO ST, LEE SC, TANG JJ, LIAW WJ: Intraarticular triamcinolone acetonide for pain control after arthroscopic knee surgery. Attest. Analg. (1998) 87:1113–1116.
   PubMedGoogle Scholar
• MAZDISNIAN F, DEGREGORIO MAZDISNIAN E PALMIERI A: Intralesional injection of triamcinolone in the treatment of lichen sclerosus. I Reprod. Med. (1999) 44:332–334.
   PubMedGoogle Scholar
• MACKEY JR, WOOD L, NABHOLTZ J, JENSEN J, VENNER P: A Phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites. Pain Symptom Manage. (2000) 19:193–199.
   PubMedGoogle Scholar
• MAISCH B, RISTIC AS, SEFEROVIC PM, SPODICK DH: Intraperitoneal treatment of autoreactive myocarditis with triamcinolon. Successful administration in patients with minimal pericardial effusion. Herz (2000) 25:781–786.
   Google Scholar